Decorin deficiency promotes hepatic carcinogenesis.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Hepatocellular carcinoma (HCC) is a rapidly spreading cancer often preceded by inflammation-driven fibrosis or cirrhosis.
• The tumor microenvironment significantly influences cancer cell behavior during malignant transformation.
• Decorin, a small leucine-rich proteoglycan, inhibits tumorigenesis by blocking receptor tyrosine kinases (RTKs).

Purpose of the Study:

• To investigate the role of decorin in hepatocarcinogenesis.
• To characterize signaling events in decorin-deficient models of liver cancer.

Main Methods:

• Used two experimental models of hepatocarcinogenesis (thioacetamide and diethyl nitrosamine).
• Genetically ablated decorin in experimental animals.
• Analyzed tumor occurrence, cell signaling pathways, protein levels, and RTK phosphorylation.

Main Results:

• Decorin deficiency led to increased tumor occurrence compared to wild-type animals.
• Lack of decorin resulted in decreased p21(WAF1/CIP1) and elevated retinoblastoma protein phosphorylation.
• Decorin deficiency caused constitutive activation of four RTKs, including PDGFRα, EGFR, IGF-IR, and MSPR/RON.

Conclusions:

• Decorin plays a crucial in vivo role in suppressing hepatocarcinogenesis.
• Loss of decorin facilitates liver cancer development by creating a pro-tumorigenic microenvironment.
• Decorin holds potential as an antitumor agent for liver cancer treatment.